IPO Candy | TalkMarkets | Page 5
IPO Stock Analysis
Contributor's Links: IPO Candy
IPO Candy provides insight, research, content and analysis of companies that have recently come public. We partner with research analysts, firms and information providers to produce a broad and deep set of information services. We will also be offering a very efficient and easy to use method of ...more

All Contributions

Latest Posts
65 to 80 of 122 Posts
<<< 1 ... 3 4 5 6 7 8 >>>
Twillo Looks To Join Apigee In The Api Software Space
There are lots of eyes on the Twilio (TWLO) IPO this week. It’s scheduled to price tonight. So far the IPO market in 2016 has been dominated by healthcare deals. Normally we tend to have a more balanced mix with more technology deals like Twilio.
Cotivti Is Ugly But Appealing For Investors
Cotiviti is one of the dominant companies in medical billing and payments space. They have tweaked their positioning to be more data-savvy and call themselves an "analytics-driven payment accuracy" company.
Secureworks IPO (SWCX) – Using Learning For “Holistic” Security
With a projected market capitalization of around $1B shares of SCWX will appeal to a broad array of investors – it will have appeal for both small-cap and mid-cap managers, funds and ETFs.
Intellia Jumps On CRISPR IPO Bandwagon
Editas (EDIT) proved that investor interest in its area is high. Intellia is another high-quality player. These are really call options “worth” about $1B each right now.
BATS IPO Works This Time
Last night BATS priced a greater than expected number of shares at the high end of their IPO price range - $19/share.
Etsy Or Regretsy?
Despite the great story and successful pricing, Etsy has not done well as a public company.
Hutchinson China Meditech Is A Monster
HCM uses a hybrid strategy - they are a major drug seller and distributor and they use that growing profitable cash flow to fund new drug development.
Syndax IPO Reboot May Help The Fight Against Cancer Tumors
Syndax Pharmaceuticals Inc. is set to price its Nasdaq IPO this Wed. night, 3.2.2016. The company will offer 4.4 million shares at an expected price range of $14 to $16.
A CRISPR View Of Editas Medicine Inc.
Editas completed their IPO this week in a difficult market and is now the first "pure play" on CRISPR. As we evaluate Editas as an investment opportunity we'll cover some of the advantages CRISPR offers in terms of drug development.
First 2016 IPO Candy Folio Updates
As we start 2016 it's a good time to review and update all our positions in the folio. We're eliminating quite a few and adding some new names. Generally we are hanging on to many of our best performers.
IPO Candy Folio Review
As we start 2016 it's a good time to review and update all our positions in the folio. We're eliminating quite a few and adding some new names. Generally we are hanging on to many of our best performers.
All Cheer Atlassian
Atlassian is planning to price their IPO next week. It's a hot deal, being led by the dream team of Goldman Sachs and Morgan Stanley with seven other banks on the cover.
No Love For Match
Online romance is a good business to start, just ask the founders of Meetic or Plenty of Fish. But it may not be nearly as good to be an equity holder of a “rollup” of dating sites which is what Match Group (Nasdaq: MTCH) is all about.
Mimecast Salad
Mimecast (Nasdaq: MIME) is a SaaS/Cloud company focused on enterprise email security and archiving. The story is a little mixed up though.
Measuring Square
Square is coming public as a $1B revenue company with quite a few moving parts.
Xtera Communications IPO
XCOM is growing rapidly but is still fairly small. They should do about $60M in revenues this year - on which they will lose about $5M. The company is offering 5.5M shares at a $10 mid-point.
65 to 80 of 122 Posts
<<< 1 ... 3 4 5 6 7 8 >>>